Publication: Preferential suppression of yellow head virus (YHV) envelope protein gp116 in shrimp that survive challenge with YHV
1
0
Issued Date
2008
Resource Type
File Type
application/pdf
ISSN
1775103
DOI
Other identifier(s)
2-s2.0-42249093009
Rights Holder(s)
Scopus
Bibliographic Citation
Diseases of Aquatic Organisms. Vol 79, No.1 (2008), p.1-8
Suggested Citation
Chaivisuthangkura P., Tejangkura T., Rukpratanporn S., Longyant S., Sithigorngul W., Sithigorngul P. Preferential suppression of yellow head virus (YHV) envelope protein gp116 in shrimp that survive challenge with YHV. Diseases of Aquatic Organisms. Vol 79, No.1 (2008), p.1-8. doi:10.3354/dao01883 Retrieved from: https://hdl.handle.net/20.500.14740/4102
Abstract
The DNA sequence that encodes the first 406 amino acid residues at the N-terminus of yellow head virus (YHV) protein gp116, namely N/2 gp116ΔTM, and the DNA sequence that encodes the next 392 amino acid residues at the C-terminus of gp116 (without the transmembrane region), namely C/2 gp116ΔTM, were cloned into pGEX-6P-1 plasmid and expressed in E. coli. Both recombinant proteins were expressed, purified by SDS-PAGE and used to immunize mice. The mouse anti-recombinant N/2 gp116 and C/2 gp116 antisera bound specifically to both the recombinant proteins and to natural gp116 protein in YHV-infected haemolymph as shown by Western blotting and in tissues as shown by immunohistochemistry. Immunohistochemical localization of YHV using anti-gp116 antiserum or monoclonal antibodies specific to gp116 (V3-2B), gp64 (Y18) and p20 (Y19) revealed similar immunoreactivity patterns for all these reagents in muscle and mandibular tissue in shrimp showing gross signs of yellow head disease. However, in gill, hepatopancreas, lymphoid organ and thoracic ganglion tissues from experimental YHV-infected shrimp (Penaeus vannamei and Palaemon serrifer) that did not show signs of disease, immunoreactivity to gp116 was reduced or absent while that for gp64 and p20 remained intense. Thus, some shrimp species were able to selectively inhibit the synthesis of gp116 in a manner that was associated with absence of gross signs of disease. © Inter-Research 2008.
Subject(s)
Antiserum
Recombinant protein
Virus antibody
Virus envelope protein
Amino acid
Antibody
Crustacean
Immunoassay
Protein
Viral disease
Animal
Article
Escherichia coli
Female
Gene expression regulation
Genetics
Immunohistochemistry
Metabolism
Mouse
Nidovirales
Palaemonidae
Penaeidae
Physiology
Reverse transcription polymerase chain reaction
Sensitivity and specificity
Virology
Western blotting
Animals
Antibodies, Viral
Blotting, Western
Escherichia coli
Female
Gene Expression Regulation, Viral
Immune Sera
Immunohistochemistry
Mice
Palaemonidae
Penaeidae
Recombinant Proteins
Reverse Transcriptase Polymerase Chain Reaction
Roniviridae
Sensitivity and Specificity
Viral Envelope Proteins
Decapoda (Crustacea)
Escherichia coli
Litopenaeus vannamei
Mus
Palaemon serrifer
Penaeus monodon
Yellow head virus
Recombinant protein
Virus antibody
Virus envelope protein
Amino acid
Antibody
Crustacean
Immunoassay
Protein
Viral disease
Animal
Article
Escherichia coli
Female
Gene expression regulation
Genetics
Immunohistochemistry
Metabolism
Mouse
Nidovirales
Palaemonidae
Penaeidae
Physiology
Reverse transcription polymerase chain reaction
Sensitivity and specificity
Virology
Western blotting
Animals
Antibodies, Viral
Blotting, Western
Escherichia coli
Female
Gene Expression Regulation, Viral
Immune Sera
Immunohistochemistry
Mice
Palaemonidae
Penaeidae
Recombinant Proteins
Reverse Transcriptase Polymerase Chain Reaction
Roniviridae
Sensitivity and Specificity
Viral Envelope Proteins
Decapoda (Crustacea)
Escherichia coli
Litopenaeus vannamei
Mus
Palaemon serrifer
Penaeus monodon
Yellow head virus
